CRS logo

CRS

Carpenter Technology Corporation

$453.69
+$19.57(+4.51%)
59
Overall
50
Value
60
Tech
68
Quality
How is this score calculated?
Market Cap
$15.36B
Volume
741.99K
52W Range
$228.00 - $475.69
Target Price
$456.13

Latest News for CRS

Corsair (CRSR) Stock Surges as It Expands into AI Infrastructure
Vince Condarcuri4 days agoMay 22, 2026

Shares of Corsair ($CRSR) are surging today after the computer hardware company announced its move into AI infrastructure with the launch of CORSAI......

J.P. Morgan Remains a Buy on Carpenter Technology (CRS)
TipRanks Auto-Generated Intelligence Newsdesk8 days agoMay 18, 2026

J.P. Morgan analyst Bill Peterson maintained a Buy rating on Carpenter Technology yesterday and set a price target of $470.00. Peterson covers the ......

J.P. Morgan Remains a Buy on Carpenter Technology (CRS)
TipRanks Auto-Generated Intelligence Newsdesk8 days agoMay 18, 2026

J.P. Morgan analyst Bill Peterson maintained a Buy rating on Carpenter Technology yesterday and set a price target of $470.00. Peterson covers the ......

Crest Nicholson Executives Acquire Shares Under Incentive Plan
TipRanks UK Auto-Generated Newsdesk15 days agoMay 12, 2026

The latest update is out from Crest Nicholson Holdings ( ($GB:CRST) ). Crest Nicholson has disclosed share transactions involving its senior leader......

Aclaris Therapeutics (ACRS) Gets a Buy from Piper Sandler
TipRanks Auto-Generated Intelligence Newsdesk16 days agoMay 11, 2026

Piper Sandler analyst Biren Amin maintained a Buy rating on Aclaris Therapeutics today and set a price target of $11.00. According to TipRanks, Ami......

Guggenheim Keeps Their Buy Rating on Aclaris Therapeutics (ACRS)
TipRanks Auto-Generated Intelligence Newsdesk16 days agoMay 11, 2026

Guggenheim analyst Seamus Fernandez reiterated a Buy rating on Aclaris Therapeutics today and set a price target of $12.00. According to TipRanks, ......

Aclaris Therapeutics (ACRS) Gets a Buy from Piper Sandler
TipRanks Auto-Generated Intelligence Newsdesk16 days agoMay 11, 2026

Piper Sandler analyst Biren Amin maintained a Buy rating on Aclaris Therapeutics today and set a price target of $11.00. According to TipRanks, Ami......

Guggenheim Keeps Their Buy Rating on Aclaris Therapeutics (ACRS)
TipRanks Auto-Generated Intelligence Newsdesk16 days agoMay 11, 2026

Guggenheim analyst Seamus Fernandez reiterated a Buy rating on Aclaris Therapeutics today and set a price target of $12.00. According to TipRanks, ......

Analysts Offer Insights on Healthcare Companies: Medline (MDLN), Aclaris Therapeutics (ACRS) and Alkermes (ALKS)
Christine Brown16 days agoMay 11, 2026

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Medline (MDLN), Aclaris Therapeutics (ACRS) and Alkermes (ALKS). ......

Analysts’ Top Healthcare Picks: Silence Therapeutics (SLN), Aclaris Therapeutics (ACRS)
Brian Anderson18 days agoMay 08, 2026

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Silence Therapeutics (SLN), Aclaris Therapeutics (AC......

News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 24 articles.

ABCD
1SymbolPriceChangeVol
2CRS$453.69+4.5%741.99K
3
4
5
6

Get Carpenter Technology Corporation Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.